Lurbinectedin for treating advanced platinum-resistant ovarian cancer [ID1340]

  • In development
  • GID-TA10313
  • Expected publication date: TBC

Status:
In progress
Technology type:
Medicine
Decision:
Prioritised
Process:
STA Standard

Timeline

Key events during the development of the guidance:

Date Update
21 March 2017 In progress. Topic referred

For further information on our processes and methods, please see our CHTE processes and methods manual